BioMarin Pharmaceuticals
BMRN
BMRN
515 hedge funds and large institutions have $16.1B invested in BioMarin Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 191 increasing their positions, 188 reducing their positions, and 76 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
2% more repeat investments, than reductions
Existing positions increased: 191 | Existing positions reduced: 188
7% less funds holding
Funds holding: 554 → 515 (-39)
43% less first-time investments, than exits
New positions opened: 43 | Existing positions closed: 76
Holders
515
Holding in Top 10
14
Calls
$139M
Puts
$86.9M
Top Buyers
| 1 | +$258M | |
| 2 | +$251M | |
| 3 | +$76.2M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$70.2M |
| 5 |
BlackRock
New York
|
+$52.4M |
Top Sellers
| 1 | -$112M | |
| 2 | -$96.6M | |
| 3 | -$65.3M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$52.8M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$47.4M |